GO:0031398 positive regulation of protein ubiquitination: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031398 describes any process that activates or increases the addition of ubiquitin groups to a protein, a central post-translational modification controlling protein stability, localization and interactions.
• Positive regulation of ubiquitination is executed by E1 activating, E2 conjugating and E3 ligase enzymes, with E3 ligases providing substrate specificity and being counter-regulated by deubiquitinases.
• Dysregulated ubiquitination drives cancer, fibrosis and immune disorders, as shown for VHL, Itch, XIAP, UBE2S and TRIM7/RNF90 [1,5,7,8].
• Ubiquitination crosstalk with UFMylation and autophagy adaptors such as SQSTM1 shapes p53 stability and starvation responses [2,6].
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test causality of ubiquitination regulators in disease [4,5,7].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect positive regulation of protein ubiquitination at scale.
Description
Positive regulation of protein ubiquitination (GO:0031398) is the biological process that activates or increases the frequency, rate or extent of ubiquitin attachment to target proteins. Ubiquitination is a reversible post-translational modification in which the 76-amino-acid ubiquitin moiety is covalently linked to lysine residues of substrates through a three-enzyme cascade, and its positive regulation determines whether a protein is degraded, relocated or functionally reprogrammed. Because this process controls the half-life of most short-lived regulatory proteins, it is a focal point for understanding cell signaling, immunity and cancer [1,4]. The importance of GO:0031398 extends beyond proteolysis. E3 ligases such as VHL and Itch positively regulate ubiquitination of immune and oncogenic substrates, while UBE2S can enhance E3-independent polyubiquitination of VHL to promote glycolysis in hepatocellular carcinoma [1,7]. In non-small cell lung cancer, the circular RNA circNDUFB2 destabilizes IGF2BPs by promoting their ubiquitination, linking this process to anti-tumor immunity. Similarly, XIAP-mediated ubiquitination of YTHDC1 promotes bladder cancer metastasis, illustrating how positive regulation of ubiquitination can be co-opted by tumors. This article integrates the QuickGO definition of GO:0031398 with verified PubMed literature to outline its mechanism, key genes, disease relevance and the CRISPR-based research methods used to study it. Researchers can use this framework to design loss-of-function, point-mutation and knock-in experiments that test whether a candidate regulator causally drives ubiquitination in a given biological context [1,4,5,7].
positive regulation of protein ubiquitination At A Glance
| GO ID | GO:0031398 |
|---|---|
| GO term | positive regulation of protein ubiquitination |
| Ontology | biological_process |
| Synonym | activation of protein ubiquitination; stimulation of protein ubiquitination; up regulation of protein ubiquitination; up-regulation of protein ubiquitination; upregulation of protein ubiquitination |
| Major function | Increases the conjugation of ubiquitin to substrate proteins, thereby controlling their stability, localization or activity. |
| Key enzymes | E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzymes and E3 ubiquitin ligases such as VHL, Itch, XIAP, UBE2S and TRIM7/RNF90 [1,5,7,8]. |
| Counter-regulation | Deubiquitinases remove ubiquitin and oppose positive regulation. |
| Disease relevance | Cancer, fibrosis, immune dysregulation and autophagy-related pathology [1,3,4,5,7,8]. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, proteomics and ubiquitination assays [4,5,7]. |
What Is GO:0031398?
GO:0031398, positive regulation of protein ubiquitination, refers to any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein. In practice, this includes increased activity or expression of E1, E2 or E3 enzymes, enhanced substrate recruitment, or inhibition of deubiquitinases, all of which shift the balance toward higher ubiquitin conjugation on target proteins.
Why Is positive regulation of protein ubiquitination Important in Cell Biology?
Positive regulation of protein ubiquitination is important because it determines the fate of a large fraction of the proteome and is frequently rewired in disease. E3 ligases such as VHL and Itch control immune signaling and tumor suppression, and their dysregulation alters substrate ubiquitination in cancer and autoimmunity. In endometriosis, multi-omics integration has highlighted ubiquitination as a driver of fibrosis, suggesting that positive regulation of ubiquitination contributes to extracellular matrix remodeling. In lung cancer, circNDUFB2 promotes ubiquitination and destabilization of IGF2BPs, activating anti-tumor immunity, which demonstrates that enhancing ubiquitination can be therapeutically beneficial. Conversely, XIAP-mediated ubiquitination of YTHDC1 promotes bladder cancer metastasis, showing that positive regulation can also be oncogenic. Understanding GO:0031398 therefore informs target selection, biomarker discovery and the design of CRISPR models that test causality [1,4,5,7].
• Controls protein half-life and abundance, making it central to virtually all signaling pathways.
• Determines immune cell activation and tolerance through E3 ligases such as Itch and VHL.
• Drives cancer progression when oncogenic substrates are stabilized or tumor suppressors are degraded [4,5,7].
• Contributes to fibrosis in endometriosis through ubiquitination-dependent remodeling.
• Interacts with UFMylation to regulate p53 stability, linking ubiquitination to stress responses.
• Coordinates autophagy and ribophagy via SQSTM1 and ATG7 ubiquitination during starvation or infection [6,8].
• Provides druggable nodes, including E3 ligases and deubiquitinases, for therapeutic intervention.
• Enables CRISPR-based functional genomics to identify causal ubiquitination regulators [4,5,7].
• Serves as a biomarker axis in multi-omics studies of inflammatory and fibrotic disease.
• Underpins experimental models for metastasis, metabolism and host-pathogen interaction [5,7,8].
What Happens During positive regulation of protein ubiquitination?
Activation of the ubiquitin cascade
In simple terms: The cell switches on a three-step tagging system that attaches ubiquitin to a target protein.
Positive regulation begins with activation of the E1 ubiquitin-activating enzyme, which uses ATP to form a thioester with ubiquitin. The ubiquitin is then transferred to an E2 conjugating enzyme, and an E3 ligase brings the E2 and the substrate together so that ubiquitin is attached to a lysine on the target protein. Increased expression or activity of any of these enzymes, or enhanced substrate recruitment, constitutes positive regulation of protein ubiquitination.
Substrate recognition and E3 ligase specificity
In simple terms: E3 ligases act like address labels that decide which protein gets tagged.
E3 ligases such as VHL, Itch, XIAP, UBE2S and TRIM7/RNF90 provide substrate specificity and are the most common targets of positive regulation [1,5,7,8]. For example, XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1, while TRIM7/RNF90 promotes autophagy via regulation of ATG7 ubiquitination during Listeria monocytogenes infection [5,8]. In non-small cell lung cancer, circNDUFB2 destabilizes IGF2BPs by promoting their ubiquitination, illustrating how a regulatory RNA can positively regulate E3-mediated substrate modification.
Polyubiquitin chain formation and topology
In simple terms: Ubiquitin can be added as a single tag or as chains, and the chain shape changes the outcome.
Positive regulation can increase monoubiquitination or extend polyubiquitin chains on substrates. UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL, showing that chain extension can occur through non-canonical mechanisms. The topology of the chain, such as K48- or K63-linkage, determines whether the substrate is degraded, redirected or used as a signaling scaffold.
Crosstalk with UFMylation and autophagy adaptors
In simple terms: Ubiquitination talks to other tagging systems and to the recycling machinery.
UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination, demonstrating that positive regulation of ubiquitination can be opposed by competing modifications. During starvation, TFEB coordinates autophagosome biogenesis and ribophagy via SQSTM1, a process in which ubiquitinated cargo is recognized by autophagy adaptors. Thus, positive regulation of ubiquitination is integrated with nutrient-sensing and autophagic pathways [2,6].
Reversal by deubiquitinases
In simple terms: Enzymes called deubiquitinases can erase the tag, so positive regulation is a balance.
Deubiquitinases remove ubiquitin from substrates and therefore counteract positive regulation of protein ubiquitination. The net ubiquitination state of a protein reflects the opposing activities of E3 ligases and deubiquitinases, and perturbations in either side can shift the process. This balance is critical in immune regulation by E3 ligases such as VHL and Itch.
Key Genes Involved in GO:0031398 positive regulation of protein ubiquitination
The following genes and proteins are experimentally implicated in positive regulation of protein ubiquitination or in its downstream consequences, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VHL | E3 ligase component that positively regulates ubiquitination of hypoxia and immune substrates [1,7] | Tumor suppressor and target of E3-independent polyubiquitination in hepatocellular carcinoma |
| ITCH | E3 ligase that positively regulates ubiquitination in immune signaling | Immune regulation and autoimmunity models |
| XIAP | E3 ligase that ubiquitylates YTHDC1 | Bladder cancer metastasis |
| UBE2S | E2 enzyme that enhances polyubiquitination of VHL | Hepatocellular carcinoma glycolysis |
| TRIM7/RNF90 | E3 ligase that regulates ATG7 ubiquitination | Autophagy during L. monocytogenes infection |
| SQSTM1 | Autophagy adaptor recognizing ubiquitinated cargo | Starvation-induced ribophagy |
| TFEB | Transcription factor coordinating autophagosome biogenesis with SQSTM1 | Nutrient stress and autophagy |
| ATG7 | Autophagy-related protein regulated by ubiquitination | Host-pathogen autophagy |
| YTHDC1 | RNA-binding protein ubiquitylated by XIAP | Cancer metastasis |
| IGF2BP | RNA-binding protein destabilized by ubiquitination | Non-small cell lung cancer and anti-tumor immunity |
| circNDUFB2 | Circular RNA promoting ubiquitination of IGF2BPs | Lung cancer progression |
| p53 | Tumor suppressor whose stability is regulated by ubiquitination and UFMylation | Cancer biology and stress responses |
| UBA1 (E1) | Activates ubiquitin for transfer to E2 enzymes | Core ubiquitination cascade |
| E2 enzymes | Conjugate ubiquitin to substrates with E3 ligases | General ubiquitination research |
| Deubiquitinases | Remove ubiquitin and oppose positive regulation | Balance of ubiquitination |
| Itch substrates | Immune signaling proteins modified by Itch | Immune regulation |
| VHL substrates | Hypoxia and signaling proteins modified by VHL | Cancer and oxygen sensing |
How Is positive regulation of protein ubiquitination Regulated?
Positive regulation of protein ubiquitination is itself regulated at multiple levels. E3 ligase abundance and activity can be increased transcriptionally or post-translationally, and deubiquitinases provide an opposing brake. Nutrient and stress signals impinge on this process; for example, TFEB coordinates autophagosome biogenesis and ribophagy via SQSTM1 during starvation, linking metabolic state to ubiquitin-dependent cargo recognition. UFMylation can antagonize ubiquitination of p53, showing that competing ubiquitin-like modifications tune the net ubiquitination of a substrate. In infection, TRIM7/RNF90 regulates ATG7 ubiquitination to promote autophagy, indicating that pathogen sensing can positively regulate ubiquitination. Together, these layers ensure that ubiquitination is context-dependent and reversible [1,2,6,8].
positive regulation of protein ubiquitination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XIAP | Bladder cancer metastasis | Knockout and overexpression in bladder cancer cell lines |
| UBE2S | Hepatocellular carcinoma glycolysis | Point mutation and knockout in liver cancer cells |
| circNDUFB2 | Non-small cell lung cancer and anti-tumor immunity | Overexpression and knockdown in lung cancer cells |
| TRIM7/RNF90 | Autophagy during L. monocytogenes infection | Knockout in macrophage or epithelial infection models |
| VHL | Hypoxia signaling and cancer [1,7] | Knock-in and knockout in renal or liver cancer models [1,7] |
Cancer
Positive regulation of protein ubiquitination is frequently rewired in cancer. XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1, and UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL [5,7]. In non-small cell lung cancer, circNDUFB2 inhibits progression by destabilizing IGF2BPs and activating anti-tumor immunity, showing that enhanced ubiquitination can be tumor-suppressive. UFMylation maintains p53 stability by antagonizing its ubiquitination, further linking this process to tumor suppression.
Fibrosis and endometriosis
Multi-omics integration has highlighted the role of ubiquitination in endometriosis fibrosis, suggesting that positive regulation of ubiquitination contributes to fibrotic remodeling. This positions ubiquitination regulators as candidate targets for antifibrotic strategies.
Immune regulation and infection
Immune regulation by protein ubiquitination involves E3 ligases such as VHL and Itch, which control the stability of immune signaling proteins. During Listeria monocytogenes infection, TRIM7/RNF90 promotes autophagy via regulation of ATG7 ubiquitination, linking positive regulation of ubiquitination to host defense.
Autophagy and metabolic stress
TFEB coordinates autophagosome biogenesis and ribophagy during starvation via SQSTM1, a process dependent on ubiquitinated cargo recognition. This connects positive regulation of ubiquitination to nutrient stress and organelle quality control.
From positive regulation of protein ubiquitination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the E3 ligase required for substrate ubiquitination? | CRISPR knockout of the E3 ligase [1,5] |
| Does a specific residue on the substrate accept ubiquitin? | Point mutation of the acceptor lysine [2,7] |
| Does a disease-associated variant alter ubiquitination? | Knock-in of the variant [4,5] |
| Where does the ubiquitinated protein localize? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression drive transformation or metastasis? | Overexpression of the ligase or substrate [5,7] |
| Which genes modify the ubiquitination phenotype? | CRISPR library screening |
How to Study the positive regulation of protein ubiquitination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ubiquitination assay | Direct ubiquitin conjugation to substrate | Validate E3 ligase activity |
| Immunoprecipitation and ubiquitin blot | Ubiquitinated substrate levels in cells [1,5] | Test positive regulation by ligases [1,5] |
| Mass spectrometry proteomics | Ubiquitinated proteins and sites | Map ubiquitination landscape |
| CRISPR knockout | Loss-of-function effect on ubiquitination [4,5] | Test causality of ligases [4,5] |
| Point mutation | Requirement of specific residues [2,7] | Identify acceptor lysines [2,7] |
| Knock-in tagging | Localization and interactions | Track ubiquitinated cargo |
| Overexpression | Gain-of-function phenotypes [5,7] | Model oncogenic ubiquitination [5,7] |
| Autophagy flux assay | Degradation of ubiquitinated cargo [6,8] | Study infection and starvation [6,8] |
Ubiquitination assays
In vitro ubiquitination assays reconstitute E1, E2, E3, ubiquitin and substrate to measure positive regulation directly. In cells, immunoprecipitation of the substrate followed by ubiquitin immunoblotting detects ubiquitin conjugates and is widely used to validate E3 ligase activity [1,5].
Proteomics and multi-omics
Mass spectrometry-based proteomics identifies ubiquitinated proteins and sites, while multi-omics integration has been used to highlight the role of ubiquitination in endometriosis fibrosis. These approaches can map the downstream consequences of positive regulation of ubiquitination.
Functional genomics with CRISPR
CRISPR knockout, point mutation, knock-in and overexpression enable causal testing of ubiquitination regulators [4,5,7]. For example, knockout of XIAP or UBE2S can reveal whether they are required for metastasis or glycolysis, respectively [5,7].
Imaging and autophagy flux
Fluorescent tagging of substrates and autophagy markers allows visualization of ubiquitin-dependent trafficking and ribophagy during starvation. TRIM7/RNF90-dependent ATG7 ubiquitination can be monitored by autophagy flux assays during infection.
How CRISPR Can Be Used to Study GO:0031398 positive regulation of protein ubiquitination
Knockout
CRISPR knockout of E3 ligases such as XIAP or UBE2S removes positive regulation of ubiquitination and reveals substrate stabilization or loss of downstream phenotypes [5,7]. Knockout of TRIM7/RNF90 impairs ATG7 ubiquitination and autophagy during infection.
Point Mutation
Point mutation of ubiquitin acceptor lysines on substrates such as p53 or VHL tests whether a specific residue is required for positive regulation and downstream effects [2,7]. This approach distinguishes direct ubiquitination from indirect effects [2,7].
Knock-in
Knock-in of tagged or disease-associated variants allows tracking of ubiquitinated proteins in their native context, as illustrated by studies of SQSTM1-dependent cargo recognition. Knock-in models can also test whether a cancer-associated mutation alters ubiquitination efficiency [4,5].
Overexpression
Overexpression of ligases or substrates such as XIAP, UBE2S or circNDUFB2 drives gain-of-function phenotypes including metastasis, glycolysis or anti-tumor immunity [4,5,7]. Overexpression is useful for confirming sufficiency of positive regulation of ubiquitination [4,5,7].
How EDITGENE Supports positive regulation of protein ubiquitination Research
Researchers studying positive regulation of protein ubiquitination-related genes often need to determine whether a candidate gene is causally involved in substrate ubiquitination, disease progression or therapy response. EDITGENE provides validated CRISPR cell models and screening services that enable this causal testing across knockout, point-mutation, knock-in and overexpression formats.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein ubiquitination research.
Frequently Asked Questions About positive regulation of protein ubiquitination
What is positive regulation of protein ubiquitination (GO:0031398)?
It is any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein, as defined by GO:0031398.
What genes are involved in positive regulation of protein ubiquitination?
Key genes include E3 ligases such as VHL, ITCH, XIAP, UBE2S and TRIM7/RNF90, as well as E1 and E2 enzymes and substrates like p53 and YTHDC1 [1,2,5,7,8].
How does ubiquitination regulate protein stability?
Ubiquitin chains on substrates can target them for degradation or alter their interactions, and positive regulation increases this tagging.
What is the role of E3 ligases in GO:0031398?
E3 ligases provide substrate specificity and are the most common effectors of positive regulation of ubiquitination [1,5,7,8].
Is positive regulation of ubiquitination involved in cancer?
Yes, it is rewired in bladder cancer, hepatocellular carcinoma and non-small cell lung cancer through XIAP, UBE2S and circNDUFB2 [4,5,7].
How is ubiquitination reversed?
Deubiquitinases remove ubiquitin and oppose positive regulation, maintaining a dynamic balance.
What methods study positive regulation of protein ubiquitination?
In vitro ubiquitination assays, immunoprecipitation, proteomics, CRISPR knockout, point mutation, knock-in and overexpression are commonly used [1,3,4,5,7].
Can CRISPR knockout help study ubiquitination?
Yes, knockout of ligases such as XIAP or UBE2S removes positive regulation and reveals downstream phenotypes [5,7].
What diseases are linked to ubiquitination dysregulation?
Cancer, endometriosis fibrosis, immune disorders and autophagy-related pathology have been linked to ubiquitination changes [1,3,4,5,8].
How does UFMylation interact with ubiquitination?
UFMylation maintains p53 stability by antagonizing its ubiquitination, showing crosstalk between ubiquitin-like modifications.
Conclusion
GO:0031398, positive regulation of protein ubiquitination, is a central biological process that controls protein fate through the coordinated action of E1, E2 and E3 enzymes and their opposition by deubiquitinases. Its dysregulation contributes to cancer, fibrosis, immune disorders and autophagy-related pathology, as demonstrated for VHL, Itch, XIAP, UBE2S, TRIM7/RNF90, circNDUFB2 and p53 [1,2,3,4,5,7,8]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with proteomics and multi-omics, provide the tools needed to test causality and identify therapeutic targets within this process [3,4,5,7]. EDITGENE supports these efforts with validated cell models and screening services tailored to positive regulation of protein ubiquitination.
References
- 1. Aki D et al.. 2019. Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch.. Protein Cell 10(6):395-404 PMID: 30413999
- 2. Liu J et al.. 2020. UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.. Nat Cell Biol 22(9):1056-1063 PMID: 32807901
- 3. Yang M et al.. 2024. Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis.. J Transl Med 22(1):445 PMID: 38735939
- 4. Li B et al.. 2021. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.. Nat Commun 12(1):295 PMID: 33436560
- 5. Sun N et al.. 2025. XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1.. Cell Death Dis 16(1):205 PMID: 40133252
- 6. Iavazzo M et al.. 2026. TFEB coordinates autophagosome biogenesis and ribophagy during starvation via SQSTM1.. Sci Adv 12(1):eaea9302 PMID: 41477847
- 7. Zhang R et al.. 2024. UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL.. Clin Mol Hepatol 30(4):771-792 PMID: 38915206
- 8. Wang J et al.. 2023. TRIM7/RNF90 promotes autophagy via regulation of ATG7 ubiquitination during L. monocytogenes infection.. Autophagy 19(6):1844-1862 PMID: 36576150
